In addition, low expression of WASF2 in glioma was correlated with increased survival rate (Figure 3d), whereas the ANKRD17 expression was suggested to have little effect on the survival rate of patients (Figure 3e). The gene discussed is ANKRD17; the disease is central nervous system cancer.